vTitan Corporation Inc.

vTitan Corporation Inc. develops innovative healthcare technology, focusing on infusion therapy and IV monitoring systems that enhance drug administration efficacy and patient safety in clinical settings. Founded in 2012, vTitan Corporation Inc. is based in Pleasanton, US, and specializes in healthcare technology aimed at improving infusion therapy.

The company raised venture funding in January 2017 from Zoho Corporation. vTitan has conducted a total of 1 deal since inception. vTitan specializes in advanced healthcare technology, primarily focusing on infusion therapy and IV monitoring systems. Their core product offerings include innovative medical devices designed for the controlled administration of drugs and fluids through non-oral routes, enhancing treatment safety and efficacy.

The systems enable continuous monitoring and targeted drug delivery, allowing hospital caregivers to manage multiple patients efficiently through an integrated platform. This unified dashboard consolidates critical parameters and alerts, enabling prompt clinical actions and improving patient outcomes. vTitan’s products cater primarily to healthcare providers, including hospitals and clinics, and are marketed in various geographical regions, including Southeast Asia, the Middle East, and select European countries. vTitan generates revenue through the sale of its medical devices and equipment, structured primarily as B2B transactions with hospitals and healthcare facilities.

Clients typically procure these products through direct purchases or long-term partnerships, often involving recurring orders based on patient needs and hospital requirements. The company may also offer service contracts or maintenance agreements to ensure continuous operation and support for their devices. Specific flagship products are integral to their revenue model, addressing critical care requirements in the healthcare sector. Pricing plans reflect the advanced technology and effectiveness of their solutions, positioning vTitan competitively in the healthcare technology market.

In 2017, vTitan Corporation Inc. raised an undisclosed amount of venture funding from Zoho Corporation, which will be utilized to support the development of new products designed for enhanced infusion therapy and monitoring solutions. The company plans to expand its market presence in Southeast Asia, the Middle East, and select European countries by 2020, targeting healthcare providers in these regions with its advanced medical technologies.